Free Hemoglobin Concentration in Severe Sepsis: Methods of Measurement and Prediction of Outcome

Overview

Journal Crit Care

Specialty Critical Care

Date 2012 Jul 18

PMID 22800762

Citations 79

Authors

Michael Adamzik

Tim Hamburger

Frank Petrat

Jurgen Peters

Herbert de Groot

Matthias Hartmann

Affiliations

Soon will be listed here.

Abstract

Introduction: Hemolysis can be induced in sepsis via various mechanisms, its pathophysiological importance has been demonstrated in experimental sepsis. However, no data on free hemoglobin concentrations in human sepsis are available. In the present study we measured free hemoglobin in patients with severe sepsis as well as in postoperative patients using four methods. It was our aim to determine the potential value of free hemoglobin as a biomarker for diagnosis and outcome of severe sepsis in critical illness.

Methods: Plasma concentration of free hemoglobin was determined in patients with severe sepsis (n = 161) and postoperative patients (n = 136) on day 1 of diagnosis and surgery. For the measurement of free hemoglobin, an enzyme linked immunosorbent assay and three spectrophotometric algorithms were used. Moreover, SAPS II- and SOFA scores as well as procalcitonin concentration and outcome were determined. Kaplan-Meier analysis was performed and odds ratios were determined after classification of free hemoglobin concentrations in a high and low concentration group according to the median. For statistical evaluation the Mann-Whitney test and logistic regression analysis were used.

Results: In non-survivors of severe sepsis, free hemoglobin concentration was twice the concentration compared to survivors. Thirty-day survival of patients, as evidenced by Kaplan-Meier analysis, was markedly lower in patients with high free hemoglobin concentration than in patients with low free hemoglobin concentration. Best discrimination of outcome was achieved with the spectrophotometric method of Harboe (51.3% vs. 86.4% survival, p < 0.001; odds ratio 6.1). Multivariate analysis including free hemoglobin, age, SAPS II- and SOFA-score and procalcitonin demonstrated that free hemoglobin, as determined by all 4 methods, was the best and an independent predictor for death in severe sepsis (p = 0.022 to p < 0.001). Free hemoglobin concentrations were not significantly different in postoperative and septic patients in three of four assays. Thus, free hemoglobin can not be used to diagnose severe sepsis in critical illness.

Conclusions: Free hemoglobin is an important new predictor of survival in severe sepsis.

Citing Articles

Association of LVV-Hemorphin-7 with Sepsis and Shock: Roles of Cathepsin D and G in Hemoglobin Metabolism in a Prospective ICU Cohort Study.

Wu Y, Chung H, Chen Y, Chen H, Chen I, Su W Biomedicines. 2025; 12(12.

PMID: 39767696 PMC: 11673980. DOI: 10.3390/biomedicines12122789.

Association of acetaminophen use with mortality and renal recovery in patients with sepsis-associated acute kidney injury.

Li L, Zhang L, Ye Y, Su Q, Leong K, Yin H BMC Anesthesiol. 2024; 24(1):440.

PMID: 39604841 PMC: 11603937. DOI: 10.1186/s12871-024-02756-7.

Cellular Mechanisms of Lung Injury: Current Perspectives.

Meegan J, Rizzo A, Schmidt E, Bastarache J Clin Chest Med. 2024; 45(4):821-833.

PMID: 39443000 PMC: 11499619. DOI: 10.1016/j.ccm.2024.08.004.

Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.

He R, Yue G, Dong M, Wang J, Cheng C Int J Mol Sci. 2024; 25(16).

PMID: 39201697 PMC: 11354379. DOI: 10.3390/ijms25169010.

Association between acetaminophen administration and outcomes in critically ill patients with gout and hypertension.

Yi X, Xie B, Hu Y, Gong T, Chen M, Cui X Front Pharmacol. 2024; 15:1445975.

PMID: 39193324 PMC: 11348437. DOI: 10.3389/fphar.2024.1445975.

References

Belcher J, Beckman J, Balla G, Balla J, Vercellotti G . Heme degradation and vascular injury. Antioxid Redox Signal. 2009; 12(2):233-48. PMC: 2821146. DOI: 10.1089/ars.2009.2822. View

BORNSIDE G, Bouis Jr P, COHN Jr I . Hemoglobin and Escherichia coli, a lethal intraperitoneal combination. J Bacteriol. 1968; 95(5):1567-71. PMC: 252177. DOI: 10.1128/jb.95.5.1567-1571.1968. View

Roth R, Kaca W, Levin J . Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res. 1994; 388:161-72. View

Figueiredo R, Fernandez P, Mourao-Sa D, Porto B, Dutra F, Alves L . Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007; 282(28):20221-9. DOI: 10.1074/jbc.M610737200. View

Huffman D, Bischof L, Griffitts J, Aroian R . Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol. 2004; 293(7-8):599-607. DOI: 10.1078/1438-4221-00303. View

Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza F, Japiassu A . A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010; 2(51):51ra71. DOI: 10.1126/scitranslmed.3001118. View

Schaer D, Alayash A . Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid Redox Signal. 2009; 12(2):181-4. DOI: 10.1089/ars.2009.2923. View

Lin T, Kwak Y, Sammy F, He P, Thundivalappil S, Sun G . Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010; 202(4):624-32. PMC: 2932749. DOI: 10.1086/654929. View

Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. DOI: 10.1016/j.cell.2006.02.015. View

10.

Pishchany G, McCoy A, Torres V, Krause J, Crowe Jr J, Fabry M . Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe. 2010; 8(6):544-50. PMC: 3032424. DOI: 10.1016/j.chom.2010.11.002. View

11.

Gonzalez M, Bischofberger M, Pernot L, van der Goot F, Freche B . Bacterial pore-forming toxins: the (w)hole story?. Cell Mol Life Sci. 2007; 65(3):493-507. PMC: 11131829. DOI: 10.1007/s00018-007-7434-y. View

12.

Tullius M, Harmston C, Owens C, Chim N, Morse R, McMath L . Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci U S A. 2011; 108(12):5051-6. PMC: 3064333. DOI: 10.1073/pnas.1009516108. View

13.

Christaki E, Opal S . Is the mortality rate for septic shock really decreasing?. Curr Opin Crit Care. 2008; 14(5):580-6. DOI: 10.1097/MCC.0b013e32830f1e25. View

14.

Fairbanks V, Ziesmer S, OBrien P . Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem. 1992; 38(1):132-40. View

15.

Poschl J, Leray C, Ruef P, Cazenave J, Linderkamp O . Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med. 2003; 31(3):924-8. DOI: 10.1097/01.CCM.0000055366.24147.80. View

16.

Nieuwland R, Berckmans R, McGregor S, Boing A, Romijn F, Westendorp R . Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000; 95(3):930-5. View

17.

Gozzelino R, Jeney V, Soares M . Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010; 50:323-54. DOI: 10.1146/annurev.pharmtox.010909.105600. View

18.

HARBOE M . A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest. 1959; 11:66-70. DOI: 10.3109/00365515909060410. View

19.

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6. DOI: 10.1097/01.CCM.0000050454.01978.3B. View

20.

Hod E, Zhang N, Sokol S, Wojczyk B, Francis R, Ansaldi D . Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010; 115(21):4284-92. PMC: 2879099. DOI: 10.1182/blood-2009-10-245001. View